|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61P 37/00 | (2018.01) | ||
| A61P 37/00 | (2006.01) | ||
| C07K 16/2866 | (2013.01) | ||
| C07K2317/21 | (2013.01) | ||
| C07K2317/76 | (2013.01) | ||
| A61K2039/505 | (2013.01) | ||
| A61K2039/545 | (2013.01) | ||
| C07K 16/2803 | (2013.01) | ||
| C07K2317/24 | (2013.01) | ||
| A61K 39/00 | (2013.01) |
| (11) | Number of the document | 4058060 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20804531.0 |
| Date of filing the European patent application | 2020-11-11 | |
| (97) | Date of publication of the European application | 2022-09-21 |
| (45) | Date of publication and mention of the grant of the patent | 2025-02-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2020/081770 |
| Date | 2020-11-11 |
| (87) | Number | WO 2021/094378 |
| Date | 2021-05-20 |
| (30) | Number | Date | Country code |
| 201962933672 P | 2019-11-11 | US | |
| 202063031848 P | 2020-05-29 | US | |
| 202063089345 P | 2020-10-08 | US |
| (72) |
BERGLIND, Anna , SE
ABREU, Gabriel , SE
PINEDA, Lilia , US
TUMMALA, Raj , US
ASKANASE, Anca , US
RICHEZ, Christophe , FR
MORAND, Eric , AU
BRUCE, Ian , GB
BROHAWN, Philip , GB
FURIE, Richard , US
BAE, Sang-Cheol , KR
TANAKA, Yoshiya , JP
WERTH, Victoria , US
VOLLENHOVEN, Ronald Van , NL
ISENBERG, David , GB
VITAL, Ed , GB
KAHLENBERG, Michelle , US
KALYANI, Rubana , US
KALUNIAN, Kenneth , US
|
| (73) |
Astrazeneca AB ,
151 85 Södertälje,
SE
|
| (54) | TYPE I INTERFERON INHIBITION IN SYSTEMIC LUPUS ERYTHEMATOSUS |
| TYPE I INTERFERON INHIBITION IN SYSTEMIC LUPUS ERYTHEMATOSUS |